COLES N ANTHONY — SEC Form 4 filings
SEC reporting owner CIK 1197018. 11 Form 4 filings on record with FilingPulse; latest filed 2026-01-06.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-02-08 to 2026-01-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 7 filings — 277,506 shares, $11,494,370 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 23.
- Largest priced transaction: sale of 50,000 shares @ $42.33 ($2,116,640) in Cerevel Therapeutics Holdings, Inc., filed 2024-04-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Cerevel Therapeutics Holdings, Inc. (CERE) | Director | 9 | — | 7 legs · 277,506 sh · $11,494,370 | 19 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | Director | 2 | — | — | 4 |
Form 4 filings — COLES N ANTHONY
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-06 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 155 @ $0 · Grant/award (A): 1,962 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 166 @ $0 · Grant/award (A): 1,958 (derivative) @ $0 | EDGAR |
| 2024-08-05 | 4 | Cerevel Therapeutics Holdings, Inc. (CERE) | Disposition to issuer (D): 15,638 · Disposition to issuer (D): 10,290 · Disposition to issuer (D): 4,809,418 (derivative) · Disposition to issuer (D): 46,322 (derivative) @ $0 | EDGAR |
| 2024-07-03 | 4 | Cerevel Therapeutics Holdings, Inc. (CERE) | Option exercise (M): 25,000 @ $3.50 · Sale (S): 25,000 @ $41.18 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Cerevel Therapeutics Holdings, Inc. (CERE) | Grant/award (A): 10,290 | EDGAR |
| 2024-06-05 | 4 | Cerevel Therapeutics Holdings, Inc. (CERE) | Option exercise (M): 50,000 @ $3.50 · Sale (S): 50,000 @ $40.61 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2024-05-14 | 4 | Cerevel Therapeutics Holdings, Inc. (CERE) | Option exercise (M): 50,000 @ $3.50 · Sale (S): 50,000 @ $42.10 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2024-04-03 | 4 | Cerevel Therapeutics Holdings, Inc. (CERE) | Option exercise (M): 50,000 @ $3.50 · Sale (S): 50,000 @ $42.33 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2024-03-06 | 4 | Cerevel Therapeutics Holdings, Inc. (CERE) | Option exercise (M): 50,000 @ $3.50 · Sale (S): 50,000 @ $41.01 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2024-03-04 | 4 | Cerevel Therapeutics Holdings, Inc. (CERE) | Option exercise (M): 50,000 @ $3.50 · Sale (S): 50,000 @ $41.16 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2024-02-08 | 4 | Cerevel Therapeutics Holdings, Inc. (CERE) | Option exercise (M): 15,440 · Sale (S): 2,506 @ $41.54 · Option exercise (M): 15,440 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1197018 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →